Effect of Alogliptin Combined with Pioglitazone on β-Cell Function and Insulin Resistance in Metformin-Treated Patients with Type 2 Diabetes

被引：0
|
作者：
Defronzo, Ralph A.
Burant, Charles F.
Fleck, Penny
Wilson, Craig
Mekki, Qais
Pratley, Richard
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A519 / A519
页数：1
相关论文
共 50 条
  • [1] Effect of alogliptin combined with pioglitazone on beta cell function and insulin resistance in metformin-treated patients with type 2 diabetes
    Burant, C.
    Fleck, P.
    Wilson, C.
    Mekki, Q.
    Pratley, R.
    DeFronzo, R.
    DIABETOLOGIA, 2009, 52 : S314 - S315
  • [2] Effect of alogliptin combined with pioglitazone on glycaemic control in metformin-treated patients with type 2 diabetes
    DeFronzo, R.
    Burant, C.
    Fleck, P.
    Wilson, C.
    Mekki, Q.
    Pratley, R.
    DIABETOLOGIA, 2009, 52 : S295 - S295
  • [3] Effect of Alogliptin Combined with Pioglitazone on Glycemic Control in Metformin-Treated Patients with Type 2 Diabetes
    Defronzo, Ralph A.
    Burant, Charles F.
    Fleck, Penny
    Wilson, Craig
    Mekki, Qais
    Pratley, Richard E.
    DIABETES, 2009, 58 : A519 - A520
  • [4] Efficacy and Tolerability of the DPP-4 Inhibitor Alogliptin Combined with Pioglitazone, in Metformin-Treated Patients with Type 2 Diabetes
    DeFronzo, R. A.
    Burant, C. F.
    Fleck, P.
    Wilson, C.
    Mekki, Q.
    Pratley, R. E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05): : 1615 - 1622
  • [5] Effect of Combination Therapy with Alogliptin and Pioglitazone in Drug-Naive Patients with Type 2 Diabetes on β-Cell Function and Insulin Resistance
    Inzucchi, Silvio E.
    Rosenstock, Julio
    Seufert, Jochen
    Fleck, Penny
    Wilson, Craig
    Mekki, Qais
    DIABETES, 2009, 58 : A520 - A520
  • [6] Effect of Alogliptin Combined With Pioglitazone on Lipids and Lipoprotein Particles in Patients With Type 2 Diabetes
    Fleck, Penny
    Wilson, Craig
    DIABETES, 2012, 61 : A300 - A300
  • [7] The Effect of Alogliptin and Alogliptin Combined With Pioglitazone on β-cell Function in Type 2 Diabetic Patients: A Randomized Double-Blind Controlled Trial
    Moller-Goede, Diane L.
    Eliasson, Bjorn
    Van Raalte, Daniel H.
    Mari, Andrea
    Tura, Andrea
    Eeg-Olofsson, Katarina
    Wilson, Craig
    Ceder-Holm, Jan
    Fleck, Penny
    Taskinen, Marja R.
    Smith, Ulf
    Diamant, Michaela
    DIABETES, 2012, 61 : A267 - A267
  • [8] Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function
    van Bommel, Erik J. M.
    Ruiter, Danique
    Muskiet, Marcel H. A.
    van Baar, Michael J. B.
    Kramer, Mark H. H.
    Nieuwdorp, Max
    Joles, Jaap A.
    Bjornstad, Petter
    van Raalte, Daniel H.
    DIABETES CARE, 2020, 43 (01) : 228 - 234
  • [9] Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
    Holland, Daniel Q.
    Neumiller, Joshua J.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 277 - 288
  • [10] Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes
    Bunck, Mathijs C.
    Corner, Anja
    Ellasson, Bjorn
    Heine, Robert J.
    Shaginian, Rimma M.
    Taskinen, Marja-Riitta
    Smith, Ulf
    Yki-Jarvinen, Hannele
    Diamant, Michaela
    DIABETES CARE, 2011, 34 (09) : 2041 - 2047
12345